September 30, 2024, JOHNSON CITY, TN
LabConnect, Inc. is pleased to announce the appointment of Wesley P. Wheeler to serve as its Chief Executive Officer and member of the Board of Directors. Wes brings over two decades of leadership experience and a proven track record of delivering growth and operational excellence across multiple high-profile companies within the pharmaceutical services industry.
With a wealth of expertise, having served as CEO/President of five different companies, Wes is well-equipped to lead LabConnect through its next phase of growth and international expansion. His appointment signals a strategic move as the company continues its upward trajectory in delivering innovative central lab services to a global clientele.
Before joining LabConnect, Wes served as President of UPS Healthcare, overseeing a $10 billion business unit, after his role as CEO of Marken where he built the industry’s leading global logistics company. Mr. Wheeler previously served as President of Valeant Pharmaceuticals (now Bausch Health), CEO of Patheon (now part of ThermoFisher), and Divisional CEO of DSM Pharmaceuticals. His early career includes more than a decade in leadership roles at GlaxoSmithKline, most recently as Senior Vice President of Global Manufacturing & Supply.
"Wes’s deep industry knowledge and experience make him the perfect fit for LabConnect. We are thrilled to welcome him to the team and confident that he will lead the company to even greater achievements.”
— Tim Johnson, LabConnect’s Chairman and Partner at BroadOak Capital
Wes also serves on several boards, including Chairman of BioTouch and Board Director at Mallinckrodt Pharmaceuticals, Evotec, Envirotainer and Argenta.
"I have worked with LabConnect for many years and am excited to join the company at this pivotal time. The company’s unique service offerings and business model position it perfectly to meet the evolving needs of the industry. I look forward to working with our team and partners to accelerate LabConnect’s growth both domestically and internationally."
— Wes Wheeler, LabConnect Chief Executive Officer
We are the world's most agile central laboratory solutions partner.
About LabConnect
LabConnect is the world’s most agile central laboratory solutions partner, providing technology-driven, customized, orchestrated, and scalable support services for clinical trials of all sizes and complexity. With over 20 years experience and 2,000+ clinical studies across 93 countries, LabConnect is the trusted partner for biotechnology, pharmaceutical, and clinical research organizations.
With modern operations and strategic alliances with world-leading laboratories, LabConnect is uniquely positioned to provide access to the latest innovation and automation. LabConnect delivers exceptional service with a comprehensive suite of central laboratory solutions including custom lab kits, advanced sample tracking and integrated logistics, global standardized sample processing, industry-leading testing menu of 20,000+ validated assays, worldwide support for radiopharmaceuticals, and next-generation biorepository.
LabConnect scientific experts support pre-clinical and clinical studies with scientific project management, bioanalytical and biospecimen management, biomarker strategy and logistics solutions. LabConnect excels at data management, integrating complex datasets from diverse sources into a single, cohesive, submission-ready dataset.
Media Contact
Ashley Nichols - anichols@LabConnect.com
Let’s Get Started
Explore how you can accelerate your clinical trial with LabConnect’s end-to-end central lab services and functional service provider solutions.
